Everpar Advisors LLC lifted its position in CME Group Inc. (NASDAQ:CME – Free Report) by 15.7% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,786 shares of the financial services provider’s stock after acquiring an additional 243 shares during the period. Everpar Advisors LLC’s holdings in CME Group were worth $415,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in CME. Truvestments Capital LLC acquired a new stake in CME Group in the third quarter valued at $26,000. Dunhill Financial LLC lifted its stake in CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares during the last quarter. Fortitude Family Office LLC grew its holdings in CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 83 shares during the period. Thurston Springer Miller Herd & Titak Inc. increased its position in CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after buying an additional 74 shares during the last quarter. Finally, Anchor Investment Management LLC increased its position in CME Group by 52.4% during the third quarter. Anchor Investment Management LLC now owns 378 shares of the financial services provider’s stock worth $83,000 after buying an additional 130 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research analysts have recently commented on the company. The Goldman Sachs Group lifted their target price on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $255.00 to $250.00 in a research report on Monday, January 6th. Royal Bank of Canada reissued a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research report on Monday, January 6th. Barclays lifted their target price on shares of CME Group from $231.00 to $257.00 and gave the stock an “equal weight” rating in a report on Monday, December 9th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus price target of $229.27.
CME Group Price Performance
CME Group stock opened at $232.31 on Friday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $249.02. The stock has a market capitalization of $83.72 billion, a P/E ratio of 24.43, a price-to-earnings-growth ratio of 4.93 and a beta of 0.56. The stock has a fifty day moving average of $232.95 and a 200-day moving average of $219.42.
CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the firm earned $2.25 earnings per share. The business’s quarterly revenue was up 18.4% on a year-over-year basis. On average, sell-side analysts expect that CME Group Inc. will post 10.2 earnings per share for the current fiscal year.
CME Group Increases Dividend
The business also recently disclosed a dividend, which was paid on Thursday, January 16th. Investors of record on Friday, December 27th were paid a $5.80 dividend. This is an increase from CME Group’s previous dividend of $2.50. The ex-dividend date of this dividend was Friday, December 27th. CME Group’s dividend payout ratio is presently 48.37%.
CME Group announced that its board has authorized a share buyback plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its stock is undervalued.
Insider Buying and Selling at CME Group
In related news, insider Sunil Cutinho sold 4,500 shares of CME Group stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the sale, the insider now directly owns 27,053 shares in the company, valued at $6,131,291.92. This trade represents a 14.26 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the transaction, the insider now owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. This trade represents a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 7,274 shares of company stock worth $1,648,071 over the last quarter. Corporate insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Investing In Preferred Stock vs. Common Stock
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Roth IRA Calculator: Calculate Your Potential Returns
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
- Insider Trades May Not Tell You What You Think
- Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.